Cytomed Therapeutics Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$1.00

-0.02 (-1.96%)

As of Jun 29, 10:38 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,331.0% upside

Low Target $15.00

Average Target $24.31

High Target $29.94

Current Price $1.00

Current
$1.00

Target
$24.31

$15.00 $24.31 avg $29.94

Scenario Analysis

Bear Case

$15.00

1,400.0%

Low target

Base Case

$24.31

+2,331.0%

Avg target

Bull Case

$29.94

+2,894.0%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$3.68

-72.8% from high

52-Week Low

$0.68

+47.0% from low

Target vs 52W High

$24.31

+560.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%